(Q36575445)

15 August 2017

1 reference

title

Mechanisms of disease: Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome (English)

1 reference

15 August 2017

1 reference

1 reference

2

Paul M Stewart

0 references

Jeremy W Tomlinson

object named as

Jeremy W Tomlinson

series ordinal

1

0 references

publication date

1 December 2005

1 reference

Nature Clinical Practice Endocrinology and Metabolism

15 August 2017

published in

1 reference

15 August 2017

volume

1

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

92-99

1 reference

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Meta-analysis: pharmacologic treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Inhibition of food intake in obese subjects by peptide YY3-36

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Expression of 11 beta-hydroxysteroid dehydrogenase using recombinant vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

A transgenic model of visceral obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Does central obesity reflect "Cushing's disease of the omentum"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Tissue-specific dysregulation of cortisol metabolism in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11beta-hsd) type 1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

In the search for specific inhibitors of human 11beta-hydroxysteroid-dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

11 beta-hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Novel enzymological profiles of human 11beta-hydroxysteroid dehydrogenase type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

11beta-Hydroxysteroid dehydrogenase type 1: tissue-specific expression and reductive metabolism of some anti-insect agent azole analogues of metyrapone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxysteroid dehydrogenase type 1 in human lung

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

21 January 2018

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

7 January 2021

Effect of chenodeoxycholic acid on 11beta-hydroxysteroid dehydrogenase in various target tissues

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Effects of glycyrrhetinic acid derivatives on hepatic and renal 11beta-hydroxysteroid dehydrogenase activities in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Compound library development guided by protein structure similarity clustering and natural product structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Type 1 11beta -hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Aged transgenic mice with increased glucocorticoid sensitivity in pancreatic beta-cells develop diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Lack of tissue glucocorticoid reactivation in 11beta -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

Cortisol effects on body mass, blood pressure, and cholesterol in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

7 January 2021

Down-regulation of adipose 11beta-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

7 January 2021

Lack of relationship between 11beta-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

7 January 2021

Evidence for distinct isoforms of 11 beta-hydroxysteroid dehydrogenase in the ovine liver and kidney

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

7 January 2021

Reduction of the Potential Anticancer Drug Oracin in the Rat Liver In-vitro

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

7 January 2021

Selective inhibition of human type 1 11beta-hydroxysteroid dehydrogenase by synthetic steroids and xenobiotics

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

7 January 2021

11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0023

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0023

1 reference

15 August 2017

1 reference